|
Volumn 35, Issue 9, 2015, Pages 1571-1573
|
Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLIC CITRULLINATED PEPTIDE ANTIBODY;
METHOTREXATE;
METHYLPREDNISOLONE;
PREDNISONE;
RHEUMATOID FACTOR;
RITUXIMAB;
ANTIRHEUMATIC AGENT;
ADULT;
AGED;
CD4+ T LYMPHOCYTE;
CLINICAL ARTICLE;
FEMALE;
HUMAN;
LETTER;
MALE;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
TREATMENT RESPONSE;
ARTHRITIS, RHEUMATOID;
BLOOD;
DRUG EFFECTS;
LYMPHOCYTE COUNT;
MIDDLE AGED;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
CD4-POSITIVE T-LYMPHOCYTES;
FEMALE;
HUMANS;
LYMPHOCYTE COUNT;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
RITUXIMAB;
TREATMENT OUTCOME;
|
EID: 84939470129
PISSN: 01728172
EISSN: 1437160X
Source Type: Journal
DOI: 10.1007/s00296-015-3295-0 Document Type: Letter |
Times cited : (17)
|
References (5)
|